Number of shares outstanding for Novavax (NVAX)

Number of shares outstanding as of December 2025 : 162,353,000

According to Novavax's latest financial reports and stock price the company's current number of shares outstanding is 162,353,000. At the end of 2025 the company had 162,353,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Novavax from 2019 to 2025

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2025	0.16 B	1.32%
2024	0.16 B	54.93%
2023	0.10 B	29.57%
2022	79.82 M	5.49%
2021	75.67 M	15.13%
2020	65.72 M	134.21%
2019	28.06 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Agenus AGEN	31,886,000	-80.36%	🇺🇸 USA
Sarepta Therapeutics SRPT	100,237,000	-38.26%	🇺🇸 USA
Emergent BioSolutions EBS	53,200,000	-67.23%	🇺🇸 USA
BioCryst Pharmaceuticals BCRX	210,176,000	29.46%	🇺🇸 USA
AstraZeneca AZN	3,102,000,000	1,810.65%	🇬🇧 UK
Pfizer PFE	5,685,000,000	3,401.63%	🇺🇸 USA
Novartis NVS	1,926,000,000	1,086.30%	🇨🇭 Switzerland
NanoViricides NNVC	16,026,318	-90.13%	🇺🇸 USA
GlaxoSmithKline GSK	2,017,000,000	1,142.35%	🇬🇧 UK
Celldex Therapeutics CLDX	66,420,000	-59.09%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions